Tumor–stroma ratio is an independent predictor for survival in early cervical carcinoma
Authors:
- 1 January 2014
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 132 (1) , 81-86
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Expression of Secreted Protein Acidic and Rich in Cysteine in the Stroma of a Colorectal Carcinoma is Associated With Patient PrognosisAnnals of Coloproctology, 2013
- Prognostic model for survival in patients with early stage cervical cancerCancer, 2010
- Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patientsBreast Cancer Research and Treatment, 2010
- Fibroblast Growth Factor Receptor 2–Positive Fibroblasts Provide a Suitable Microenvironment for Tumor Development and Progression in Esophageal CarcinomaClinical Cancer Research, 2009
- Molecular mechanisms of cervical carcinogenesis by high‐risk human papillomaviruses: novel functions of E6 and E7 oncoproteinsReviews in Medical Virology, 2009
- Peritumoral Fibroblast SPARC Expression and Patient Outcome With Resectable Pancreatic AdenocarcinomaJournal of Clinical Oncology, 2007
- Different patterns of inflammation and prognosis in invasive carcinoma of the breastHistopathology, 2006
- Histopathologic parameters of prognosis in cervical cancer - a reviewInternational Journal of Gynecological Cancer, 2004
- Role of tissue stroma in cancer cell invasionThe Journal of Pathology, 2003
- Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group studyGynecologic Oncology, 1990